Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines

Background: Low effectiveness of chemotherapy in ovarian cancer results from development of drug resistance during treatment. Topotecan (TOP) is a chemotherapeutic drug used in second-line chemotherapy of this cancer. Unfortunately, during treatment cancer can develop diverse cellular and tissue spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sterzyńska, Karolina, Klejewski, Andrzej, Wojtowicz, Karolina, Świerczewska, Monika, Nowicki, Michał, Brązert, Jacek, Januchowski, Radosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277650/
https://www.ncbi.nlm.nih.gov/pubmed/30519347
http://dx.doi.org/10.7150/jca.27342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277650/
https://www.ncbi.nlm.nih.gov/pubmed/30519347
http://dx.doi.org/10.7150/jca.27342

Ejemplares similares